رجوع
نطاق اليوم
KWD 11.23
KWD 11.75
نطاق 52 أسبوعًا
KWD 9.85
KWD 17.18
حجم التداول
2,396,784
متوسط 50 يوم / 200 يوم
KWD 12.65
/
KWD 13.23
الإغلاق السابق
KWD 11.54
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -3.8 | 0.3 |
| P/B | 1.7 | 2.9 |
| ROE % | -36.4 | 3.7 |
| Net Margin % | -16.3 | 3.8 |
| Rev Growth 5Y % | -3.4 | 10.0 |
| D/E | 1.8 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 13.330
+16.3%
Low: KWD 12.000
High: KWD 16.000
مكرر الربحية المستقبلي
8.1
ربحية السهم المستقبلية
KWD 1.432
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
3.6 B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2029 |
KWD 1.765
KWD 1.734 – KWD 1.804
|
3.8 B | 1 |
| FY2028 |
KWD 1.742
KWD 1.057 – KWD 2.334
|
3.8 B | 5 |
| FY2027 |
KWD 1.558
KWD 1.448 – KWD 1.618
|
3.7 B | 11 |
النقاط الرئيسية
Revenue declined -3.43% annually over 5 years
Generating 104.00M in free cash flow
PEG of 0.12 suggests growth is underpriced
Capital efficient — spends only 3.56% of revenue on capex
ROIC of 4.96% — low return on invested capital
النمو
Revenue Growth (5Y)
-3.43%
Revenue (1Y)-2.98%
Earnings (1Y)N/A
FCF Growth (3Y)-32.46%
الجودة
Return on Equity
-36.44%
ROIC4.96%
Net Margin-16.25%
Op. Margin6.85%
الأمان
Debt / Equity
1.84
Current Ratio1.51
Interest Coverage2.86
التقييم
P/E Ratio
-3.83
P/B Ratio1.71
EV/EBITDA17.59
Dividend Yield0.06%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -2.98% | Revenue Growth (3Y) | -3.66% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -3.43% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3.68B | Net Income (TTM) | -598.00M |
| ROE | -36.44% | ROA | -11.01% |
| Gross Margin | 50.00% | Operating Margin | 6.85% |
| Net Margin | -16.25% | Free Cash Flow (TTM) | 104.00M |
| ROIC | 4.96% | FCF Growth (3Y) | -32.46% |
| Safety | |||
| Debt / Equity | 1.84 | Current Ratio | 1.51 |
| Interest Coverage | 2.86 | Dividend Yield | 0.06% |
| Valuation | |||
| P/E Ratio | -3.83 | P/B Ratio | 1.71 |
| P/S Ratio | 0.62 | PEG Ratio | 0.12 |
| EV/EBITDA | 17.59 | Dividend Yield | 0.06% |
| Market Cap | 2.29B | Enterprise Value | 4.43B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.68B | 3.79B | 3.97B | 3.92B | 4.23B |
| Net Income | -598.00M | -910.00M | -132.00M | -950.00M | 411.00M |
| EPS (Diluted) | -3.00 | -4.48 | -0.62 | -4.41 | 1.87 |
| Gross Profit | 1.84B | 1.96B | 2.09B | 2.13B | 2.35B |
| Operating Income | 252.00M | -879.00M | -85.00M | -937.00M | 608.00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5.43B | 5.75B | 7.37B | 7.64B | 9.24B |
| Total Liabilities | 4.09B | 3.81B | 4.08B | 3.83B | 4.24B |
| Shareholders' Equity | 1.34B | 1.94B | 3.29B | 3.81B | 5.00B |
| Total Debt | 2.47B | 2.27B | 2.30B | 2.15B | 2.29B |
| Cash & Equivalents | 326.00M | 272.00M | 334.00M | 365.00M | 339.00M |
| Current Assets | 2.02B | 1.75B | 1.97B | 1.89B | 1.85B |
| Current Liabilities | 1.34B | 1.59B | 1.43B | 1.17B | 1.26B |